These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 21088654)

  • 41. Future Physicians in the Era of Precision Cardiovascular Medicine.
    Krittanawong C
    Circulation; 2017 Oct; 136(17):1572-1574. PubMed ID: 29061572
    [No Abstract]   [Full Text] [Related]  

  • 42. Next generation sequencing applications for cardiovascular disease.
    Kalayinia S; Goodarzynejad H; Maleki M; Mahdieh N
    Ann Med; 2018 Mar; 50(2):91-109. PubMed ID: 29027470
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Genetics and pharmacogenetics in the diagnosis and therapy of cardiovascular diseases.
    Krasi G; Precone V; Paolacci S; Stuppia L; Nodari S; Romeo F; Perrone M; Bushati V; Dautaj A; Bertelli M
    Acta Biomed; 2019 Sep; 90(10-S):7-19. PubMed ID: 31577248
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The continuum of personalized cardiovascular medicine: a position paper of the European Society of Cardiology.
    Kirchhof P; Sipido KR; Cowie MR; Eschenhagen T; Fox KA; Katus H; Schroeder S; Schunkert H; Priori S;
    Eur Heart J; 2014 Dec; 35(46):3250-7. PubMed ID: 25148837
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pulmonary fibrosis in the era of stratified medicine.
    Mathai SK; Newton CA; Schwartz DA; Garcia CK
    Thorax; 2016 Dec; 71(12):1154-1160. PubMed ID: 27799632
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cardiovascular genetics: paying individual dividends.
    McNally E
    Sci Transl Med; 2014 Jun; 6(239):239ed12. PubMed ID: 24898741
    [No Abstract]   [Full Text] [Related]  

  • 47. Impacts of variation in the human genome on gene regulation.
    Haraksingh RR; Snyder MP
    J Mol Biol; 2013 Nov; 425(21):3970-7. PubMed ID: 23871684
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Annotating individual human genomes.
    Torkamani A; Scott-Van Zeeland AA; Topol EJ; Schork NJ
    Genomics; 2011 Oct; 98(4):233-41. PubMed ID: 21839162
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Genetic testing in cardiovascular diseases.
    Arndt AK; MacRae CA
    Curr Opin Cardiol; 2014 May; 29(3):235-40. PubMed ID: 24717670
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Strengths and Opportunities of Network Medicine in Cardiovascular Diseases.
    Benincasa G; Marfella R; Della Mura N; Schiano C; Napoli C
    Circ J; 2020 Jan; 84(2):144-152. PubMed ID: 31866635
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Molecular diagnosis for cardiovascular diseases].
    Schulze-Bahr E; Klaassen S; Abdul-Khaliq H; Schunkert H
    Dtsch Med Wochenschr; 2015 Oct; 140(20):1538. PubMed ID: 26445261
    [No Abstract]   [Full Text] [Related]  

  • 52. Advances in genomic testing.
    Donoghue S; Downie L; Stutterd C
    Aust Fam Physician; 2017; 46(4):200-205. PubMed ID: 28376572
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Annotation of functional variation in personal genomes using RegulomeDB.
    Boyle AP; Hong EL; Hariharan M; Cheng Y; Schaub MA; Kasowski M; Karczewski KJ; Park J; Hitz BC; Weng S; Cherry JM; Snyder M
    Genome Res; 2012 Sep; 22(9):1790-7. PubMed ID: 22955989
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Revealing the human mutome.
    Chen JM; Férec C; Cooper DN
    Clin Genet; 2010 Oct; 78(4):310-20. PubMed ID: 20569258
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Whole Genome Sequencing-Based Discovery of Structural Variants in Glioblastoma.
    Wrzeszczynski KO; Felice V; Shah M; Rahman S; Emde AK; Jobanputra V; O Frank M; Darnell RB
    Methods Mol Biol; 2018; 1741():1-29. PubMed ID: 29392687
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Genomic medicine and risk prediction across the disease spectrum.
    Kotze MJ; Lückhoff HK; Peeters AV; Baatjes K; Schoeman M; van der Merwe L; Grant KA; Fisher LR; van der Merwe N; Pretorius J; van Velden DP; Myburgh EJ; Pienaar FM; van Rensburg SJ; Yako YY; September AV; Moremi KE; Cronje FJ; Tiffin N; Bouwens CS; Bezuidenhout J; Apffelstaedt JP; Hough FS; Erasmus RT; Schneider JW
    Crit Rev Clin Lab Sci; 2015; 52(3):120-37. PubMed ID: 25597499
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Personalized Management of Cardiovascular Disorders.
    Jain KK
    Med Princ Pract; 2017; 26(5):399-414. PubMed ID: 28898880
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prospects for personalized cardiovascular medicine: the impact of genomics.
    Ginsburg GS; Donahue MP; Newby LK
    J Am Coll Cardiol; 2005 Nov; 46(9):1615-27. PubMed ID: 16256859
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The Impact of the Emerging Genomics Data on the Management of Agerelated Phenotypes in the Context of Cellular Senescence.
    Montesanto A; Geracitano S; Garasto S; Fusco S; Lattanzio F; Passarino G; Corsonello A
    Curr Drug Targets; 2016; 17(4):428-38. PubMed ID: 25601329
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.